Peripheral Arterial Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have agreed and given written consent to take part before any study activities begin
- You are 50 years of age or older and have been diagnosed with leg artery disease causing significant leg pain when walking or serious problems with blood flow to your limbs, and you have had a successful procedure to restore blood flow in the past 14 days
- You are willing and able to have a special heart CT scan within 14 days of joining the study, and you agree to have the results shared with your treating doctor using a specific analysis tool
Who may not be able to join:
- You have already been diagnosed with heart artery disease, have had a heart attack, or have previously had a procedure to open or bypass heart arteries
- You have already had a heart artery scan or heart CT scan before joining the study
- You have a known history of certain heart rhythm problems, including second or third degree heart block, sick sinus syndrome, or long QT syndrome (confirm with trial site)
- You have severe asthma or severe lung disease (COPD) that requires regular use of inhalers to keep it under control
- You have severe heart failure that significantly limits your daily activities
- You have a serious irregular heartbeat, or you already have a pacemaker or internal defibrillator device implanted
- Your kidneys are not working well enough (based on a specific blood test measuring kidney function) (confirm with trial site)
- You have a known severe allergic reaction to the dye used in CT scans
- You are pregnant or your pregnancy status is unknown and you could potentially be pregnant
- You are currently experiencing an unstable or emergency heart condition, such as sudden chest pain, dangerously low blood pressure, heart shock, or fluid on the lungs
- You have any serious, life-threatening illness where you are not expected to live for more than 2 years
- You currently have any active infection
- You are unable to follow the study procedures as required
- You have a medical reason why you cannot safely take long-term blood-thinning or anti-clotting medication after a heart procedure (confirm with trial site)
- You have taken part in another interventional clinical trial within the past 30 days
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Dainis Krievins, MD, PhD, Institute of Science, Pauls Stradins Clinical University Hospital
Phone: +371 29450000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Major Adverse Cardiac Events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.